Long-term survival of the Lefèvre retentive cup: 12-year follow-up analysis of 466 consecutive cases.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
04 2022
Historique:
received: 12 06 2020
revised: 26 02 2021
accepted: 02 03 2021
pubmed: 14 12 2021
medline: 20 4 2022
entrez: 13 12 2021
Statut: ppublish

Résumé

The Lefèvre retentive cup is a salvage solution for total hip replacement at high risk of dislocation. Only a few studies have reported the medium or long-term survival; most often, only a small number of patients were included in these studies. This led us to conduct a retrospective analysis of a large population to determine: 1) the 10-year survival rate after primary or revision arthroplasty, 2) the complication rate. The dislocation rate is<5% for revision arthroplasty and<2% for primary arthroplasty. This single-center retrospective study included 466 consecutive total hip replacements performed with the Lefèvre retentive cup with a 12-year theoretical minimum follow-up (1/1/1998 to 31/8/2006). There were 257 indications for primary arthroplasty and 209 for revision arthroplasty. The cohort had 316 women and the mean age at surgery was 72.9years (30.2-89.9). The mean follow-up was 10.2±5 years (0.1-19.3). A statistical analysis was done based on the Kaplan-Meier survival curves in two subsets of patients: primary and revision surgery. At the final review, 264 patients had died because of reasons unrelated to the procedures (mean 7.8±4.7years after the procedure), 48 were lost to follow-up (mean 3.0±3.3years after the procedure), and 39 patients (8%) had undergone acetabular revision of which 12 were for infection (2.5%), 25 were for loosening (5.4%) (5 femoral loosening only) and 2 were for dislocation (0.4%). In all, there were 10/466 dislocations (2.1%) of which 5/257 (1.9%) were in the primary group and 5/209 (2.4%) were in the revision group: 2 had a cup exchange and 8 were reduced by closed procedures. The probability of survival free of mechanical complications at 10years was estimated at 94.8%±1.6% (95% CI: 91.6%-98.0%) for the primary group and 87.8%±2.7% (95% CI: 82.4%-93.2%) for the revision groups (p=0.0017). There were 39 re-operations in the overall cohort: 1/257 (0.4%) for dislocation, 7/257 (2.7%) for aseptic loosening and 3/257 (1.2%) for infection in the primary group, while in the revision group, 1/209 (0.5%) was for dislocation, 18/209 (8.6%) for aseptic loosening and 9/209 (4.3%) for infection. The Lefèvre retentive cup has good long-term survival with a low mechanical complication rate, both in primary and revision surgery. To us, this implant appears to be a reliable salvage procedure for total hip replacement in patients at high risk for dislocation. IV; retrospective study without control group.

Identifiants

pubmed: 34896581
pii: S1877-0568(21)00438-2
doi: 10.1016/j.otsr.2021.103173
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103173

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Hoel Letissier (H)

Service de chirurgie orthopédique et traumatologique, CHRU de la cavale blanche, 29200 Brest, France; Laboratoire de traitement de l'information médicale (LaTIM, UMR1101), bâtiment IBRBS, 22, avenue Camille-Desmoulins, 29200 Brest, France. Electronic address: hoel.letissier@chu-brest.fr.

Aurélien Barbier (A)

Service de chirurgie orthopédique et traumatologique, CHRU de la cavale blanche, 29200 Brest, France.

Ludovic Tristan (L)

Service de chirurgie irthopédique, clinique du Ter, 5, allée de la clinique du Ter, 56270 Ploemeur, France.

Frédéric Dubrana (F)

Service de chirurgie orthopédique et traumatologique, CHRU de la cavale blanche, 29200 Brest, France.

Christian Lefèvre (C)

Service de chirurgie orthopédique et traumatologique, CHRU de la cavale blanche, 29200 Brest, France; Laboratoire de traitement de l'information médicale (LaTIM, UMR1101), bâtiment IBRBS, 22, avenue Camille-Desmoulins, 29200 Brest, France.

Arnaud Clavé (A)

Laboratoire de traitement de l'information médicale (LaTIM, UMR1101), bâtiment IBRBS, 22, avenue Camille-Desmoulins, 29200 Brest, France; Service de chirurgie orthopédique, polyclinique Saint-George, 2, avenue de Rimiez, 06105 Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH